AMPE Insider Trading
Insider Ownership Percentage: 3.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Ampio Pharmaceuticals Share Price & Price History
Current Price: $0.01
Price Change: +0.30 (1.20%)
As of 02/13/2026 12:31 PM ET
Ampio Pharmaceuticals Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 6/8/2023 | J Kevin Buchi | Director | Buy | 1,250 | $6.00 | $7,500.00 | 6,250 | |
| 5/24/2023 | Michael A Martino | CEO | Buy | 3,844 | $5.80 | $22,295.20 | 3,844 | |
| 5/11/2023 | David R Stevens | Director | Buy | 2,500 | $4.40 | $11,000.00 | 2,948 | |
Ampio Pharmaceuticals Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/4/2022 | Shilanski & Associates Inc. | 937,237 | $57K | 0.0% | N/A | 0.414% |  |
| 8/2/2022 | Capital Wealth Alliance LLC | 67,000 | $64K | 0.0% | N/A | 0.030% |  |
| 7/20/2022 | Courier Capital LLC | 540,056 | $91K | 0.0% | +16.3% | 0.239% |  |
| 5/2/2022 | HNP Capital LLC | 464,356 | $0.22M | 0.0% | N/A | 0.204% |  |
| 4/28/2022 | Valeo Financial Advisors LLC | 333,574 | $0.16M | 0.0% | N/A | 0.147% |  |
| 4/18/2022 | Northcape Wealth Management LLC | 98,000 | $46K | 0.0% | N/A | 0.043% |  |
| 3/8/2022 | Bartlett & Co. LLC | 76,900 | $44K | 0.0% | N/A | 0.038% |  |
| 2/9/2022 | NTB Financial Corp | 146,100 | $83K | 0.1% | N/A | 0.072% |  |
| 2/8/2022 | Raymond James & Associates | 67,303 | $38K | 0.0% | -68.7% | 0.033% |  |
| 2/4/2022 | Beacon Investment Advisory Services Inc. | 170,447 | $97K | 0.0% | +17.6% | 0.084% |  |
| 1/26/2022 | Helen Stephens Group LLC | 117,222 | $67K | 0.1% | N/A | 0.058% |  |
| 1/25/2022 | CVA Family Office LLC | 1,137,920 | $0.65M | 0.2% | -3.0% | 0.563% |  |
| 1/20/2022 | Kestra Advisory Services LLC | 128,878 | $73K | 0.0% | N/A | 0.064% |  |
| 1/18/2022 | Courier Capital LLC | 464,356 | $0.27M | 0.0% | +17.2% | 0.230% |  |
| 11/17/2021 | Willis Investment Counsel | 2,031,840 | $3.37M | 0.2% | -7.0% | 1.005% |  |
| 11/16/2021 | Cetera Advisor Networks LLC | 20,000 | $33K | 0.0% | +100.0% | 0.010% |  |
| 11/16/2021 | Metropolitan Life Insurance Co NY | 32,469 | $54K | 0.0% | -46.5% | 0.016% |  |
| 11/12/2021 | Geode Capital Management LLC | 3,112,761 | $5.17M | 0.0% | +4.4% | 1.553% |  |
| 11/10/2021 | Citigroup Inc. | 24,009 | $40K | 0.0% | +151.3% | 0.012% |  |
| 11/9/2021 | Barclays PLC | 79,625 | $0.13M | 0.0% | +230.8% | 0.040% |  |
| 11/9/2021 | BlackRock Inc. | 12,286,154 | $20.40M | 0.0% | +1.2% | 6.129% |  |
Data available starting January 2016
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
Read More on Ampio Pharmaceuticals
Volume
716 shs
Average Volume
4,236 shs
Market Capitalization
$11.35 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Beta
6.34